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The study to investigate the bactericidal and bacteriostatic potency of 
some phyto-bactericides against selected ESBL producing bacteria was 
carried out. Methanolic leaf extracts of Chromoleana odorata, 
Lasianthera ofricana, Heinsia crinata, Piper guineense, Aspilia 
africana and Lasianthera afrciana were tested against ESBL producing 
E. coli and K. pneumonia isolated from clinical specimens (urine, 
wound swabs, stool, blood, high vaginal swab and sputum obtained 
from hospitals in  five of the six states of the South-South geo-political 
zones of Nigeria namely; Akwa-Ibom, Cross-River, Delta, Edo and 
Rivers States) using both the agar disc diffusion  and agar well 
diffusion method. Results obtained from the study revealed that all the 
plant extracts showed varying degree of antibacterial potency against 
the ESBL producing E.coli and K. pneumonia. The zones of inhibition 
increased with a corresponding increase in the concentration of the 
plant leaf extracts, with higher zones of inhibition observed at 300 
mg/ml (13.2±0.25 and 20.4±0.11mm (C. odorata); 17.1±0.09 and 
18.3±0.25mm (A. Africana); 19.8±0.73 and 10.8±0.25mm (H. crinata); 
19.2±0.39 and 24.3±0.39mm (P. guineense); 15.5±0.42 and 
18.5±0.03mm (L. africana) as against the ESBL producing E. coli and 
K. pneumonia respectively). Although, P. guineense showed the least 
minimum inhibitory concentration (50mg/ml) against the isolates, 
however the MIC of the plant extracts recorded were higher than that 
observed with the conventional antibiotic gentamicin (1.5mg/ml). The 
study has revealed that the phyto- constituents of C. odorata, A. 
africana, H. crinata, P. guineense and L. africana, have high 
antimicrobial property as compared and confirmed with commercial 
antibiogram. Hence, these plants could serve as an alternative medicine 
without side effects and in addition they could further be used to 
discover other bioactive natural products that may serve as lead for the 
development of new phyto-pharmaceuticals.        
 
                 Copy Right, IJAR, 2019,. All rights reserved. 
…………………………………………………………………………………………………….... 
Introduction:- 
ESBLs are known as extended spectrum because they are able to hydrolyze a broader spectrum of β-lactam 
antibiotics than the simple parent β-lactamases from which they are derived (Andy et al., 2019). They have ability to 
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even inactivate β-lactam antibiotics containing an oxyimino-group such as oxyimino- cephalosporin as well as 
oxyimino-monobactam (Ikegbunam et al., 2014). They are not active against cephamycins and carbapenems. 
Generally, they are inhibited by β-lactamase- inhibitors such as clavulanate and tazobactem (Muza heed et al., 
2008). ESBLs have been found in a wide range of gram-negative rods. However, the vast majority of species 
expressing these enzymes belong to the family Enterobacteriaceae (Kiratisin et al., 2007).  
 
Medicinal plants provide basic raw materials for different industries such as pharmaceutical, cosmetic, perfumery 
and food (Varalakshmi et al, 2014). The medicinal plants are referred to as plants that are used for their therapeutic 
or medicinal values (Mukesh et al., 2018). The whole plant or its different parts may be valued for its therapeutic, 
medicinal, aromatic or savory qualities (Sahid et al., 2003). They also play vital role as an antimicrobial agent. There 
has been resurgence in the consummation and demand for medicinal plants. Many plants components are now 
synthesized in large laboratories for their use in pharmaceutical preparations. A wide range of secondary metabolites 
are produced by plants which can be directly used as precursors or as principal compound for drug synthesis in 
pharmaceutical industries (Agbafor et al., 2011). It is anticipated that plant extracts exhibiting target sites other than 
those used by antibiotics can be effective against microbial pathogens which are drug resistant. Bioactive 
compounds are normally accumulated as secondary metabolites in all plant cell but their concentration is determined 
by the plant part, climate and growth phase (Dhiman et al., 2011). The highest concentration of such compounds is 
present in leaves generally preferred for therapeutic use (Dhiman et al., 2011). 
 
The antimicrobial activity of extracts of various plants has been proven scientifically. These extracts contain 
multiple active ingredients which could deter the development of resistance. Currently, there are few medicinal 
plants that have been established to have antimicrobial activity against ESBL producing organisms, hence the need 
for this present study.             
  
Material And Methods:- 
Test microorganism 
The test organism used in this study were ESBL producing bacteria isolates obtained from various clinical 
specimens (urine, wound swab, stool, blood, high vaginal swab and sputum) from two hospitals in five out of the six 
states of the South-South geopolitical zones namely; Akwa-Ibom (University of Uyo Teaching Hospital and St. 
Luke’s Hospital Anua in Uyo), Cross River (University of Calabar Teaching Hospital and General Hospital, 
Calabar), Delta (Federal Central Hospital Asaba and NNPC Clinic, Warri), Edo (University of Benin Teaching 
Hospital and Central Specialist Hospital, Benin) and Rivers (University of Port Hartcourt Teaching Hospital and 
Brait Waite-Memorial Hospital, Port Hartcourt). 
 
Herbal extract 
The plants used for this study were Chromoleana odorata, Aspilia africana, Heinsia crinata, Piper guineense  and 
Lasianthera africana. They were identified and authenticated by a taxonomist in the Department of Plant and 
Ecological studies, University of Calabar, and voucher specimens were deposited there. The leaf parts were air-dried 
at room temperature and reduced into fine powders using a mechanical blender. 100g of the powdered materials 
were extracted using 100ml analytical grade methanol (BHD laboratory, England) via cold maceration for forty -
eight hours. The resulting mixture was filtered and the filtrate was concentrated using a Rotary evaporator (Model 
RE 300,  Barloworld Scientific Ltd, UK) and kept at room temperature for the methanol to completely evaporate for 
24hrs. The resulting residue which was the methanol leaf extract of the various plants was stored in air-tight 
containers. 




Plate 1:-Lasianthera africana 
 
 
Plate 2:-Aspilia Africana 
 
 
Plate 3:-Heinsia crinata 
 




Plate 4:-Piper guineense 
 
 
Plate 5:-Chromolaena odorata 
Standard stock solutions 
Standard stock solutions of 50mg/ml, 100mg/ml, 150mg/ml, 200mg/ml, 250mg/ml and 300mg/ml of Chromoleana 
odorata, Aspilia africana, Heinsia crinata, Piper guineense  and Lasianthera africana leaves respectively, were 
prepared in dimethylsulphoxide (DMSO, BDH-Laboratory, England). Two-fold serial dilutions of the stock 
solutions were prepared while carrying out the various tests. 100µg/ml stock solution of gentamicin was diluted to 
obtain concentrations of 0.5mg/ml, 1.0mg/ml, 1.5mg/ml, 2.0mg/ml and 2.5mg/ml, which were used in this study.  
 
Sensitivity of ESBL producing organisms to the plant extracts and standard antibiotics.  
This was determined by using the disc diffusion method for the standard antibiotics and agar well diffusion method 
for the plant extracts (CLSI, 2012). Briefly, a Petri-dish was divided into five sections; one section for the stock 
solution and each dilution of a plant extract in DMSO. 0.1ml of the standardized suspension of the isolates were put 
into the empty sterile petri-dish. Bijou bottles containing 20ml of sterile molten Mueller- Hinton agar at 45
0
C was 
poured into each of the plates containing the suspension of the isolate. These were gently rotated thoroughly and 
were allowed to set for 20 minutes. Six millimeters (6mm) cork borer dimension was used to boreholes into each 
section in the plates and each section was labeled properly. About 40µl of the various concentrations of the extracts 
were placed into the wells and left for one hour at room temperature. The plates were incubated at 37
0
C for 18-24 
hours. The test was carried out in triplicates for each isolates. The experiment was carried out with all the plant 
extracts. The experiment was repeated using the standard antibiotics disc (oxoid). Ceftriaxone (30µg), 
Chloramphenicol (30µg), Ciprofloxacin (30µg), Amoxicillin (30µg), Gentamicin (30µg), Imipenem (30µg), and 
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Tetracycline (30µg) were placed on each section of the plate, up to a maximum of five sections. After the incubation 
period, the plates were observed and inhibition zone diameters (IZD) were measured. 
 
Evaluation of the minimum Inhibitory Concentration (MIC) of the plant extract 
The minimum inhibitory concentration of the extracts against E. coli and K. pneumonia expressing ESBL were 
performed using the agar dilution method (Chah et al., 2006). 19 mls of sterilized molten nutrient agar was 
aseptically poured into sterile petri-dishes containing 1ml of the graded concentrations of the extracts. The plates 
were rotated to ensure even distribution of the plant extracts and allowed to set. The plates were swabbed with 
0.05ml of standard suspension of the ESBL producing E. coli and K. pneumonia isolates. The plates were incubated 
at 37
0
c for 18-24hours. The presence of growth was observed after incubation. 
 
Results:- 
Antibiogram of ESBL producing  E.coli  and K. pneumonia isolates 
The antibiogram of the ESBL producing E. coli and K. pneumonia isolates is shown  in Table 1 below. The isolates 
were multi- drug resistant. They were resistant to amoxicillin and chloramphenicol but were sensitive to 
ciprofloxacin, gentamicin, ceftriaxone, erythromycin, tetracycline and imipenem. 
 
Sensitivity of the ESBL producing E. coli and K. pneumonia to the plant extracts  
Table 2 present the result of the antimicrobial activity of the methanolic leaf extract of C. odorata on ESBL 
producing E. coli and K. pneumonia. it showed that a higher zone of inhibition of 13.2±0.25mm and 20.4±0.27mm 
was recorded at 300mg/ml, when the extract was tested against E.coli and K. pneumonia respectively. Similarly, 
Table 3 present the result of antimicrobial activity of the methanolic leaf extract of A. Africana on ESBL producing 
E. coli and K. pneumonia. it showed that the zones of inhibition increased with a corresponding increase in the 
concentrations of the plant extract. However, a higher zone of inhibition (17.1±0.09mm and 18.3±0.25mm) was 
observed at 300mg/ml, when the extract was tested against ESBL producing E. coli and K. pneumonia respectively. 
The result of the antimicrobial activity of the methanolic leaf extract of H. crinata, P. guineense and L. Africana 
against ESBL producing E. coli and K. pneumonia are presented in Table 4, 5 and 6 respectively. At a concentration 
of 300mg/ml, a higher zones of inhibition (19.8±0.73 and 10.8±0.25mm; 19.2±0.39 and 24.3±0.39mm; 15.5±0.42 
and 18.5±0.43mm) were observed when extracts of H. crinata, P. guineense  and L. africana  were tested against 
ESBL producing E. coli and K. pneumonia. 
 
The result of the minimum inhibitory concentration of the plant extracts against the ESBL producing E. coli and K. 
pneumonia is presented in Table 7. It showed that P. guineense had the lowest minimum inhibitory concentration 
(50mg/ml) as compared to that observed with the other extracts tested against the ESBL producing E. coli and K. 
pneumonia. 
 
Table 1:-Antibiogram of ESBL producing E.coli and K. pneumonia before treatment with methanolic leaf extracts 
 Inhibition zone diameter of Antibiotics (mm) 
Isolate  CHL AMX CIP GEN CEF ERY TET IMP 
E. coli 0 0 14 13 12 13 18 29 
K. pneumonia 0 5 16 15 14 16 20 31 
Keys: CHL- Chloramphenicol, AMX- Amoxicillin, CIP- Ciprofloxacin, GEN- Gentamicin, CEF- Ceftriaxone, ERY 
– Erythromycin, TET- Tetracycline, IMP- Imipenem   
 
Table 2:-Antimicrobial activity of the methanolic leaf extract of C. odorata on ESBL producing E. coli and K. 
pneumonia 
Zones of inhibition (mm) 
Concentration (mg/ml)  E. coli K. pneumonia 
50 3.1±0.18 6.4±0.19 
100 5.3±0.19 8.6±0.21 
150 7.4±0.21 11.8±0.24 
200 9.3±0.23 15.7±0.25 
300 13.2±0.25 20.4±0.27 
*Each value represents the mean value of two determinants  
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Table 3:-Antimicrobial activity of the methanolic leaf extract of A. africana on ESBL producing E. coli and 
K.pneumonia 
Zones of inhibition (mm) 
Concentration (mg/ml)  E. coli K. penumoniae 
50 5.2±0.7 6.4±0.18 
100 7.8±0.06 9.2±0.19 
150 11.5±0.06 12.8±0.20 
200 14.3±0.08 15.3±0.24 
300 17.1±0.09 18.3±0.25 
*Each value represents the mean value of two determinants  
 
Table 4:-Antimicrobial activity of the methanolic leaf extract of H. crinata on ESBL producing E. coli and K. 
pneumonia 
Zones of inhibition (mm) 
Concentration (mg/ml)  E. coli K. penumoniae 
50 4.7±0.16 2.1±0.18 
100 7.9±0.21 3.8±0.21 
150 11.2±0.43 6.4±0.22 
200 15.4±0.56 7.3±0.22 
300 19.8±0.73 10.8±0.25 
*Each value represents the mean value of two determinants  
 
Table 5:-Antimicrobial activity of the methanolic leaf extract of P. guineense on ESBL producing E. coli and K. 
pneumonia 
Zones of inhibition (mm) 
Concentration (mg/ml)  E. coli K. pneumonia 
50 4.3±0.18 6.4±0.21 
100 7.4±0.24 11.8±0.28 
150 11.6±0.29 14.9±0.31 
200 15.3±0.31 18.6±0.32 
300 19.2±0.39 24.3±0.30 
*Each value represents the mean value of two determinants  
 
Table 6:-Antimicrobial activity of the methanolic leaf extract of L. africana on ESBL producing E. coli and K. 
pneumonia 
Zones of inhibition (mm) 
Concentration (mg/ml)  E. coli K. pneumonia 
50 4.2±0.24 5.6±0.25 
100 7.3±0.28 8.4±0.29 
150 9.4±0.31 12.5±0.31 
200 11.6±0.39 15.9±0.38 
300 15.5±0.42 18.5±0.43 
*Each value represents the mean value of two determinants  
 
Table 7:-Minimum inhibitory concentration of the plant extracts against the ESBL producing E. coli and K. 
pneumonia 
 Minimum inhibitory concentration 












E. coli 100 50 50 50 100 1.5 
K.pneumoniae 50 100 100 50 100 1.5 
      
     
 




In this study, the sensitivity of ESBL producing E. coli and K. pneumonia to imipenem was not surprising, as it is in 
accordance with previous studies by Pena et al., (1998) and Winokur et al., (2001). The resistance of the isolates to 
amoxicillin and chloramphenicol could be due to the co-existence of genes encoding drug resistance to other 
antibiotics on the plasmids which encode ESBLs (Ikegbunam et al., 2014). The methanolic leaf extracts of all the 
plants used (C. odorata, A. africana, H. crinata, P. guineense and L. africana) showed varying degree of 
antimicrobial activities against the ESBL producing E. coli and K. pneumonia tested. However, the zones of 
inhibition observed with the plant extracts increased with a corresponding increase in the concentrations of the 
extracts. This observation was not surprising as similar study by Hrindhya and Kulandhaivel (2017) reported to have 
recorded  a high zone of inhibition when leaf extract of C. odorata was tested against pyogenic pathogens. 
Odinakachukwu et al., (2019) reported to have observed the antibacterial activity of leaf extract of Chromolaena 
odorata and the effect of its combination with some conventional antibiotics on pathogenic organisms isolated from 
wounds. Studies by Anibijuwon et al., (2010) and Obioma et al., (2017) reported antimicrobial activities of leaf 
extract of Aspilia africana on some pathogenic organisms of clinical and wound origin. Anyanwu and Nwosu (2014)  
and Olusimbo et al., (2011) reported antimcoribal activities of Piper guineense against some pathogens.  
 
Amongst the plant extracts tested, P. guineense had the lowest minimum inhibitory concentration (50mg/ml) against 
the ESBL producing E. coli and K. pneumonia investigated. Although, Gentamycin had a far lower minimum 
inhibitory concentration (1.5mg/ml) against the isolates, however, all the plant extracts showed signs of antibacterial 
potency agent the tested isolates. 
 
The medicinal value of a plant can be determined on the basis of bioactive compounds. Several reports by Olusimbo 
et al., (2011); Bassey et al., (2013); Anyanwu and Nwosu (2014) and  Obioma et al., (2017) have recorded the 
presence of tannins, phenolic compounds,, flavonoids, terpenoids, glycosides and alkaloids in extracts of C. odorata, 
A. afrciana, H. crinata, P.guineense  and L. africana. The presence of these phyto-components plays a vital role in 
the antimicrobial properties of the plants. Alkaloids are major plant components responsible for antimicrobial 
activity. It intercalates with DNA and interferes with the cell division (Kigigha and Zige, 2013). Flavonoids are a 
major group of plant phenolic compounds that act as antioxidant. It forms a complex with extracellular soluble 
proteins, bacterial cell walls and also disrupts the cell membrane (Divya et al., 2014). Terpenoids are a subclass of 
prenylipids and are naturally occurring organic chemicals which damages the cell membrane (Bassey et al., 2013). 
Tannins are polymeric phenolic substances which precipitate microbial protein and also inactivate microbial 
adhesion, enzymes and cell wall envelope transport proteins (Hridhya and Kulandhaivel, 2017). 
 
Conclusion:- 
This study on the bactericidal and bacteriostatic potency of some phyto-bactericides against selected ESBL 
producing bacteria has revealed that the phyto-constituents of C. odorata, A. africana, H. crinata, P. guineense and L. 
africana have high antimicrobial property as compared and confirmed with commercial antibiogram. Since the drug 
resistance nature of bacteria have been reported to be on the increase as each day passes, these plant extracts could 
serve as an alternative medicine without side effects. In addition, these plants could further be used to discover other 
bioactive natural products that may serve as lead for the development for new phyto-pharmaceuticals.                                            
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